Barclays PLC Nu Cana PLC Transaction History

Barclays PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.02 - $2.9 $4 - $5	-2 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$1.95 - $2.85 $3 - $5	2 New	2 $0
Q2 2019 Aug 14, 2019	SELL	$9.74 - $17.45 $2,678 - $4,798	-275 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$10.92 - $18.03 $3,003 - $4,958	275 New	275 $4,000
Q4 2017 Feb 14, 2018	SELL	$10.0 - $18.72 $300,000 - $561,600	-30,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$16.15 - $18.37 $484,499 - $551,100	30,000	30,000 $551,000

3.33M

Ticker NCNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,196,000
Market Cap $59M
Description
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.